BJO

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
[Advanced]

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Read responses to this article
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this link to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Add article to my folders
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Heimann, H.
Right arrow Articles by Foerster, M. H
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Heimann, H.
Right arrow Articles by Foerster, M. H
Br J Ophthalmol 2000;84:1162-1169 ( October )

Vasoproliferative tumours of the retina

Heinrich Heimanna, Norbert Bornfeldb, Oliver Vijb, Sarah E Couplandc, Nikolaos E Bechrakisa, Ulrich Kellnera, Michael H Foerstera

a Department of Ophthalmology, University Hospital Benjamin Franklin, Free University, Berlin, Germany, b Department of Ophthalmology, University Hospital, Essen, Germany, c Department of Pathology, University Hospital Benjamin Franklin, Free University, Berlin, Germany

Correspondence to: Dr Heinrich Heimann, Augenklinik, University Hospital Benjamin Franklin, Hindenburgdamm 30, D-12200 Berlin, Germany heimann{at}ukbf.fu-berlin.de

Accepted for publication 16 May 2000

BACKGROUND---Vasoproliferative tumours of the retina (VPTR) are benign tumours of unknown origin, occurring mostly in otherwise healthy patients. VPTR may be associated with other chorioretinal diseases, such as uveitis. The tumours, which histologically represent reactive gliovascular proliferations, are characterised by a pink to yellow appearance on funduscopy and are accompanied by exudative and haemorrhagic changes of the retina.
METHODS---22 cases of VPTR in 21 patients were examined with a follow up period between 1 month and 6 years. Ophthalmological changes associated with VPTR were intraretinal and subretinal exudations (n=18), exudative detachments of the surrounding sensory retina (n=13), intraretinal and subretinal haemorrhages (n=10), exudative changes within the macula (n=10), hyperpigmentation of the retinal pigment epithelium at the border of the exudative retinal changes (n=9), and vitreous haemorrhages (n=4). Tumour biopsy was performed in two cases. Treatment consisted of plaque radiotherapy (n=14), plaque radiotherapy and cryotherapy (two), cryotherapy only (two), observation (three), and enucleation in one case of a blind and painful eye.
RESULTS---Regression of the tumour and the associated exudative changes could be observed in all treated cases. Visual acuity at last follow up improved two lines or more in two cases, remained within two lines of the initial visual acuity in 15 cases, and worsened in the remaining five. Histopathological examination of the biopsy specimens and the tumour of the enucleated eye showed massive capillary proliferation with perivascular spindle-shaped glial cells of retinal origin.
CONCLUSION---The correct diagnosis of VPTR is of importance as these lesions may lead to visual loss. Further, VPTR must be differentiated from angiomas associated with von Hippel-Lindau disease as well as from ocular and systemic malignancies. Regression of tumour thickness and associated retinal changes can be achieved with brachytherapy or cryotherapy.


© 2000 by British Journal of Ophthalmology



This article has been cited by other articles:


Home page
Arch OphthalmolHome page
V. M. L. Cohen, C. L. Shields, H. Demirci, and J. A. Shields
Iodine I 125 Plaque Radiotherapy for Vasoproliferative Tumors of the Retina in 30 Eyes
Arch Ophthalmol, September 1, 2008; 126(9): 1245 - 1251.
[Abstract] [Full Text] [PDF]


Home page
Br. J. Ophthalmol.Home page
B Damato
Vasoproliferative retinal tumour.
Br. J. Ophthalmol., April 1, 2006; 90(4): 399 - 400.
[Full Text] [PDF]


Home page
Br. J. Ophthalmol.Home page
G Anastassiou, N Bornfeld, A O Schueler, H Schilling, S Weber, D Fluehs, B Jurklies, O Vij, and W Sauerwein
Ruthenium-106 plaque brachytherapy for symptomatic vasoproliferative tumours of the retina.
Br. J. Ophthalmol., April 1, 2006; 90(4): 447 - 450.
[Abstract] [Full Text] [PDF]


Home page
Arch OphthalmolHome page
J. Wachtlin, H. Heimann, C. Jandeck, K. M. Kreusel, N. E. Bechrakis, U. Kellner, and M. H. Foerster
Bilateral Vasoproliferative Retinal Tumors With Identical Localization in a Pair of Monozygotic Twins
Arch Ophthalmol, June 1, 2002; 120(6): 860 - 862.
[Full Text] [PDF]

eLetters:

Read all eLetters

Intravitreal injection of crystalline cortisone in treatment of retinal vasoproliferative
Jost B. Jonas, Antje Soefker
BJO Online, 23 Feb 2001 [Full text]



HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
Terms and conditions relating to subscriptions purchased online  ¦  Website terms and conditions  ¦  Privacy policy
Copyright © 2000 by the BMJ Publishing Group Ltd.